PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has the TOP Net Promoter...
Read More
PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 07, 2023
PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual
MMIT Patient Choice Award, once again, has...
Read More
PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
August 02, 2023
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO®(rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States,...
Read More
PANTHERx Rare Announces Exciting Leadership Changes: New President and Key Hire
June 20, 2023
PITTSBURGH, June 21, 2023 /PRNewswire/ — PANTHERx Rare, the
nation’s leading rare disease pharmacy, is excited...
Read More
PANTHERx Rare Announces Exciting Leadership Changes: New President and Key Hire
PITTSBURGH, June 21, 2023 /PRNewswire/ — PANTHERx Rare, the nation’s leading rare disease pharmacy, is excited...
Read More
